Home »
» FDA Approves, Leqembi, New Treatment for Early Alzheimer’s
January 06, 2023
https://ift.tt/cZLaIq2
The drug, Leqembi, may modestly slow cognitive decline in early stages of the disease but carries some safety risks. Still, data suggests it is more promising than the small number of other available treatments.
Source link
source
https://financetin.com/fda-approves-leqembi-new-treatment-for-early-alzheimers/financetin.com
Related Posts:
5 Great Grills, Smokers and Pizza Ovens For Backyard CookingWhile it’s unclear when social norms are going to get back to what we all remember, don’t let this strange time stifle your enthusiasm for good backyard cooking. This is the perfect time to sharpen your culinary skills and tr… Read More- This Is the Ultimate Gift for the Fitness Lover in Your LifeThis article was produced in partnership with WHOOP.
If you’re shopping for the fitness lover in your life, the WHOOP strap really can’t be beat. Fitness is often a numbers game: How fast did you run? How far did y… Read More
- Gift Guide: The Most Memorable Gift Ideas for Any GolferIn partnership with TAG Heuer
Sure, the golfer on your list can always use a box of balls, and while they would certainly appreciate a dozen ProV1s, they will last but a fleeting few rounds. The same is true for tees, gloves,… Read More
- Kentucky Fog Is the Bourbon County Brand Stout Variant to Drink in 2020Daylight saving time is here, its unwelcome bags stuffed with 5 p.m. sunsets and a potential sales pitch for breweries. Dark days deserve dark beers. It’s marketing magic for imperial stouts, those boozy heavyweights swinging… Read More
- Financial Missteps Could Signal Future Dementia
Older people diagnosed with dementia or Alzheimer's were more likely to miss credit card payments as early as six years before their diagnosis, compared with similar people without dementia (about 8% versus 7%), the research… Read More
0 comments:
Post a Comment